WO2016111658A1 - Synthesis of thiosemicarbazone derivatives comprising sulphonamide group with potential anticonvulsant activity - Google Patents

Synthesis of thiosemicarbazone derivatives comprising sulphonamide group with potential anticonvulsant activity Download PDF

Info

Publication number
WO2016111658A1
WO2016111658A1 PCT/TR2015/050283 TR2015050283W WO2016111658A1 WO 2016111658 A1 WO2016111658 A1 WO 2016111658A1 TR 2015050283 W TR2015050283 W TR 2015050283W WO 2016111658 A1 WO2016111658 A1 WO 2016111658A1
Authority
WO
WIPO (PCT)
Prior art keywords
mixture
compound
methanol
solid substances
phenyl
Prior art date
Application number
PCT/TR2015/050283
Other languages
French (fr)
Inventor
Aysegul IYIDOGAN
Emine Elcin EMRE
Rahime Betül TOPALFAKIOGĞLU
Bedia KAYMAKÇIOĞLU
Feyza ARICIOĞLU
Original Assignee
Iyidogan Aysegul
Emre Emine Elcin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iyidogan Aysegul, Emre Emine Elcin filed Critical Iyidogan Aysegul
Publication of WO2016111658A1 publication Critical patent/WO2016111658A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C337/00Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C337/06Compounds containing any of the groups, e.g. thiosemicarbazides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C337/00Derivatives of thiocarbonic acids containing functional groups covered by groups C07C333/00 or C07C335/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C337/06Compounds containing any of the groups, e.g. thiosemicarbazides
    • C07C337/08Compounds containing any of the groups, e.g. thiosemicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. thiosemicarbazones

Definitions

  • the present invention relates to the synthesis method of thiosemicarbazone derivatives comprising sulphonamide group with high anticonvulsant activity.
  • Epilepsy disease which is also commonly called as "sara” is hard to treat and negatively affects the daily life of patients. In this disease, abnormal electricity is temporary spread in the brain cells of patients. Therefore, conscious, behavioural, emotional, mobile, or sensory functional disorder is seen in patients.
  • Anti-epileptic (anticonvulsant) drugs are used in treatment of this disease.
  • drugs with the active ingredients of phenytoin, phenobarbital , carbamazepine, sodium valproate are used. These drugs are generally preferred in epilepsy treatment, since the drugs comprising these active ingredients are inexpensive, have long time usage experience, and their adverse effects are known better. However, these drugs may interact with other drugs used by the patient and may cause adverse effects especially on women, children, and elders. Also, drug resistance can be seen in some patients and patients may have a seizure even if they use the drug.
  • Patent No. 2012/04327 can be given as an example to the known status of the art.
  • use of a pharmaceutical composition comprising an anti- epileptic/anticonvulsant active ingredient and/or its pharmaceutically acceptable salts, hydrates, isomers, and polymorphs for additional treatment of partial convulsion with or without concomitant peripheral type neuropathic pain and secondary generalized convulsion is disclosed.
  • said antiepileptic active ingredient does not have a characteristic that treats the patient and prevents the patient from having a seizure. In this case, only the pain of the patient can be treated, but the patient cannot be prevented from having a seizure.
  • the present invention relates to the synthesis method of thiosemicarbazone derivatives comprising sulphonamide group with high anticonvulsant activity.
  • this mixture is mixed at room temperature for 15 minutes. Said room temperature corresponds to 25°C in chemical literature .
  • the mixture is heated in a heater system that has a condenser.
  • reaction mixture is cooled to room temperature when it is determined that the starting material found in the reaction mixture is completely used up.
  • This reaction mixture is heated in a heater system that has a condenser for 48 hours.
  • reaction mixture is cooled down to room temperature when it is determined that the starting material found in the reaction mixture is completely used up.
  • the sulphonyl chloride group found in the structure of the 4-acetylbenzene sulphonyl chloride compound that is selected as the starting material is reacted with aniline and 4-methoxy aniline to obtain Compound 1 and Compound 2 derivatives of sulphonamide .
  • isothiocyanades carrying different substituents are treated with hydrazine monohydrate and thiosemicarbazide derivatives are obtained.
  • Compound 1 is synthesized according to the method disclosed in the first synthesis by using 3.4 grams (12.0 mmols) of 4- acetylbenzenesulphonylchloride and 1.23 grams (13.2 mmols) of aniline.
  • Melting point of Compound 1 is about 83-84 °C.
  • Compound 1 is an orange coloured substance in powder form.
  • Compound 1 is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate. However, it is insoluble in distilled water.
  • DMSO dimethyl sulphoxide
  • Table 1 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 1.
  • Compound 2 is synthesized according to the method disclosed in the first synthesis by using 3.5 grams (11 mmols) of 4- acetylbenzenesulphonylchloride and 1.21 grams (13 mmols) of 4-methoxyaniline .
  • the efficiency of Compound 2 at the end of the synthesis is 43%. That is to say, about 1.5 grams of Compound 2 is obtained .
  • Melting point of Compound 2 is about 114-115°C.
  • Compound 2 is a brown substance in powder form.
  • Compound 2 is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, However, it is insoluble in distilled water.
  • DMSO dimethyl sulphoxide
  • Table 3 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2.
  • FT-IR analysis results for Compound 2 are given below in terms of wave number (cnf 1 ) .
  • the meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
  • Melting point of Compound la is about 228-230°C. Compound la is yellow.
  • Compound la is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , heated chloroform, and heated ethyl acetate. However, it is insoluble in distilled water.
  • DMSO dimethyl sulphoxide
  • Table 5 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound la.
  • Melting point of Compound lb is about 182-184°C.
  • Compound lb is yellow. Compound lb is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , and chloroform. However, it is insoluble in distilled water and ethyl acetate. Molecular weight of Compound lb is 424.54 g/mol.
  • Table 7 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound lb.
  • FT-IR analysis results for Compound lb are given below in terms of wave number (cnf 1 ) .
  • the meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
  • Melting point of Compound lc is about 212-214°C. Compound lc is yellow.
  • Compound lc is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water.
  • DMSO dimethyl sulphoxide
  • Table 9 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound lc.
  • Compound Id is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water.
  • DMSO dimethyl sulphoxide
  • Table 11 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound Id. FT-IR analysis results for Compound Id are given below in terms of wave number (cnf 1 ) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
  • Melting point of Compound le is about 195-197°C. Compound le is light pink.
  • Compound le is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, However, it is insoluble in distilled water.
  • DMSO dimethyl sulphoxide
  • Table 13 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound le. FT-IR analysis results for Compound le are given below in terms of wave number (cnf 1 ) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
  • Table 15 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound If.
  • Table 16 FT-IR analysis results for Compound ' . Lf .
  • Melting point of Compound lg is about 183-185°C.
  • Compound lg is yellow. Compound lg is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water. Molecular weight of Compound lg is 438.57 g/mol.
  • Table 17 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound lg.
  • FT-IR analysis results for Compound lg are given below in terms of wave number (cnf 1 ) .
  • the meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
  • Melting point of Compound lh is about 195-197°C. Compound lh is yellow.
  • Compound lh is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water.
  • DMSO dimethyl sulphoxide
  • Table 19 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound lh.
  • Melting point of Compound 2a is about 220-221°C. Compound 2a is yellow.
  • Compound 2a is soluble in acetone, heated methanol, chloroform, and dimethyl sulphoxide (DMSO) . However, it is insoluble in ethyl acetate and distilled water.
  • DMSO dimethyl sulphoxide
  • Table 21 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2a.
  • Melting point of Compound 2b is about 190-191°C. Compound 2b is white.
  • Compound 2b is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
  • DMSO dimethyl sulphoxide
  • Table 23 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2b.
  • Melting point of Compound 2c is about 230-232°C. Compound 2c is yellow.
  • Compound 2c is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
  • Table 25 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2c.
  • Melting point of Compound 2d is about 227-228°C. Compound 2d is white.
  • Compound 2d is soluble in acetone, heated methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water.
  • DMSO dimethyl sulphoxide
  • Table 27 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2d. FT-IR analysis results for Compound 2d are given below in terms of wave number (cnf 1 ) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
  • Melting point of Compound 2e is about 190-191°C. Compound 2e is light pink.
  • Compound 2e is soluble in acetone, chloroform, and dimethyl sulphoxide (DMSO) . However, it is insoluble in methanol, ethyl acetate, and distilled water.
  • DMSO dimethyl sulphoxide
  • Table 29 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2e.
  • Melting point of Compound 2f is about 206-207°C. Compound 2f is brown.
  • Compound 2f is soluble in acetone, methanol, ethyl acetate, chloroform, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
  • Table 31 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2f.
  • Melting point of Compound 2g is about 238-239°C. Compound 2g is light yellow.
  • Compound 2g is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
  • Table 33 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2g.
  • Melting point of Compound 2h is about 191-192°C. Compound 2h is white.
  • Compound 2h is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
  • Table 35 Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2h. FT-IR analysis results for Compound 2h are given below in terms of wave number (cnf 1 ) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
  • HC1 is used in order to provide an acidic medium during the synthesis of p-substitutedphenyl thiosemicarbazone derivatives and the reaction efficiencies are observed to vary between 24-96%.
  • C NMR spectra of the synthesized compounds are taken from a solution of 20 milligrams (mg) of substance in CDCI 3 and DMSO-d6, in a spectrometer device at 400 MHz frequency. In said spectra, tetramethylsilane (TMS) is accepted as standard. The chemical shift values of the determined peaks are evaluated as ppm (parts per million) concentration and the interaction coefficients are given as Hz. 13 C NMR results for Compound lc, lh, 2a, and 2h in the thiosemicarbazone derivatives synthesized according to the method of the invention are given below.
  • Thin-layer chromatography is used for monitoring the process of reactions during the synthesis works and determining the purity levels of obtained compounds.
  • 20x20 cm chromatographic plates coated with 0-25 millimetre (mm) thickness of silica gel are used as adsorbent.
  • Ethyl acetate and n-hexane (3:2, 3:1, 1:1) are used as solvent system.
  • the operation of sweeping the solvent on the plates is performed after solvent systems are placed in chromatography tanks at room temperature and the tanks are saturated with solvent vapour. After the sweeping operation is complete, in order to make the stains found on the air-dried plates visible, the plates are required to be observed under UV light at 254 nanometres (nm) wavelength.
  • the plates should be placed in a closed tank saturated with iodine vapour.
  • DAB dimethylamino benzaldehyde
  • FT-IR Fast Fourier Transform-Infrared
  • Tables 46 and 47 show the closed formulas, molecular weights, melting points, and obtaining efficiencies of synthesized compounds.
  • Table 44 Closed formulas, theoretically calculated ingredient percentages, and elemental analysis (CHNS determination) results of synthesized compounds [ 1 , la-h] .
  • Table 45 Closed formulas, theoretically calculated ingredient percentages, and elemental analysis (CHNS determination) results of synthesized compounds [2, 2a-h] .
  • Table 46 Closed formulas, molecular weights, melting points, and obtaining efficiencies synthesized compounds [1, 2, la-g] .
  • Table 47 Closed formulas, molecular weights, melting points, and obtaining efficiencies synthesized compounds [lh, 2a-h] .
  • Figure 1 Chemical structure of Compound 1 (4-acetyl-N- phenylbenzenesulphonamide ) that is the product of the first synthesis .
  • Figure 14 Chemical structure of Compound 2d (N-(4- chlorophenyl) -2- ⁇ 1- [4- (4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene ⁇ hydrazine
  • Figure 15 Chemical structure of Compound 2e (N-(4- methoxyphenyl ) -2- ⁇ 1- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene ⁇ hydrazine
  • Figure 16 Chemical structure of Compound 2f (N-(4- methylthiophenyl) -2- ⁇ l-[4-(4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene ⁇ hydrazine
  • Figure 17 Chemical structure of Compound 2g (N- (benzyl ) -2- ⁇ 1- [4- (4-methoxyphenylsulphamoyl ) phenyl ] ethylidene ⁇ hydrazine carbothioamide) that is the product of the third synthesis.
  • Figure 18 Chemical structure of Compound 2h (N- (2- phenylethyl) -2- ⁇ 1- [4- (4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene ⁇ hydrazine
  • Figure 20 Chemical structure showing the protons of Compound 2a (N- (cyclohexyl) -2- ⁇ 1- [4- (4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene ⁇ hydrazine
  • Figure 21 The mechanism for obtaining Compound 1 (4-acetyl- N-phenylbenzenesulphonamide ) that is the sulphonamide derivative product of the first synthesis.
  • Figure 22 The mechanism for obtaining Compound 2 (4-acetyl- N- ( 4-methoxyphenyl ) benzenesulphonamide ) that is the sulphonamide derivative product of the first synthesis.
  • Figure 23 The mechanism for obtaining the second synthesis product thiosemicarbazide derivatives.
  • Figure 24 The mechanism for obtaining the third synthesis product thiosemicarbazone derivatives.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to the synthesis method of thiosemicarbazone derivatives comprising sulphonamide group and having high anticonvulsant/antiepileptic activity.

Description

DESCRIPTION
SYNTHESIS OF THIOSEMICARBAZONE DERIVATIVES COMPRISING SULPHONAMIDE GROUP WITH POTENTIAL ANTICONVULSANT ACTIVITY
Subject of the Invention
The present invention relates to the synthesis method of thiosemicarbazone derivatives comprising sulphonamide group with high anticonvulsant activity.
State of the Art
Product development is continuously made in clinical applications in order to reduce the side effects and toxicity of drugs used in treatment of various diseases and to ensure that the drugs show their effect in short time during the course of the treatment. Moreover, new drugs are required to be developed, since some drugs are dropped out of use in time due to not being suitable for health.
Epilepsy disease, which is also commonly called as "sara" is hard to treat and negatively affects the daily life of patients. In this disease, abnormal electricity is temporary spread in the brain cells of patients. Therefore, conscious, behavioural, emotional, mobile, or sensory functional disorder is seen in patients. Anti-epileptic (anticonvulsant) drugs are used in treatment of this disease. In the prior art, drugs with the active ingredients of phenytoin, phenobarbital , carbamazepine, sodium valproate are used. These drugs are generally preferred in epilepsy treatment, since the drugs comprising these active ingredients are inexpensive, have long time usage experience, and their adverse effects are known better. However, these drugs may interact with other drugs used by the patient and may cause adverse effects especially on women, children, and elders. Also, drug resistance can be seen in some patients and patients may have a seizure even if they use the drug.
Patent No. 2012/04327 can be given as an example to the known status of the art. In this invention, use of a pharmaceutical composition comprising an anti- epileptic/anticonvulsant active ingredient and/or its pharmaceutically acceptable salts, hydrates, isomers, and polymorphs for additional treatment of partial convulsion with or without concomitant peripheral type neuropathic pain and secondary generalized convulsion is disclosed. However, said antiepileptic active ingredient does not have a characteristic that treats the patient and prevents the patient from having a seizure. In this case, only the pain of the patient can be treated, but the patient cannot be prevented from having a seizure.
In order to eliminate the above disclosed drawbacks, compounds, which have high anticonvulsant activity and low adverse effects, does not interact with other drugs used by the patient, and have high potential for use as active ingredient in anti-epileptic/anticonvulsant drugs.
Detailed Description of the Invention
The present invention relates to the synthesis method of thiosemicarbazone derivatives comprising sulphonamide group with high anticonvulsant activity.
In general terms, said synthesis method can be described as follows .
1st Synthesis: 4-acetylbenzene is reacted with sulphonylchloride aniline and methoxyaniline at room temperature in the presence of dichloromethane, and sulphonamide derivative is obtained.
2nd Synthesis: 4-substitutedphenyl isothiocyanade derivatives are converted into thiosemicarbazide derivatives by hydrazine monohydrate at room temperature, in the presence of diethylether .
3rd Synthesis: The sulphonamide derivative obtained in the first step and the thiosemicarbazide derivative obtained in the second step are reacted during heating in the presence of methyl alcohol. As a result of this reaction, thiosemicarbazone derivatives comprising sulphonamide groups are obtained.
Detailed description of the above disclosed synthesis method is given below.
1st Synthesis:
- 1.17 mmol 4-substituted aniline derivative is dissolved in 10 mL dichloromethane.
1.06 mmol triethylamine and 1-3 drops of pyridine are added into this mixture as catalysts.
- this mixture is mixed at room temperature for 15 minutes. Said room temperature corresponds to 25°C in chemical literature .
- 1.06 mmol of 4-acetylbenzenesulphonylchloride is dissolved in 5 mL of dichloromethane in a separate place and then added dropwise onto the above prepared mixture.
- during and/or after the addition, the mixture is heated in a heater system that has a condenser.
- the reaction mixture is cooled to room temperature when it is determined that the starting material found in the reaction mixture is completely used up.
- the cooled mixture is extracted with 2 M HC1. - organic phases are dried with sodium sulphate following extraction operation.
- the crystals formed as a result of the drying operation are washed with petroleum ether.
2nd Synthesis:
- 1 mmol substituted isothiocyanade derivative is dissolved in diethylether.
- 1 mmol hydrazine monohydrate dissolved in diethylether is added dropwise into this mixture; Solid substances start to settle at the bottom of the mixture during additional processing .
- the solid substances settling at the bottom of the mixture are taken from the mixture vessel.
- solid substances are washed with water and diethylether.
- this solid substance is crystallized in a solvent.
3rd Synthesis:
- 1 mmol of thiosemicarbazide derivatives are dissolved in heated 5 mL methanol.
- 1 mmol of substituted sulphonamide derivatives dissolved in 10 mL methanol are added onto this mixture.
- This reaction mixture is heated in a heater system that has a condenser for 48 hours.
- the reaction mixture is cooled down to room temperature when it is determined that the starting material found in the reaction mixture is completely used up.
- the solid substance formed following cooling operation is taken from the mixture.
- this solid substance is crystallized in a solvent.
In the first synthesis of the method according to the invention, the sulphonyl chloride group found in the structure of the 4-acetylbenzene sulphonyl chloride compound that is selected as the starting material is reacted with aniline and 4-methoxy aniline to obtain Compound 1 and Compound 2 derivatives of sulphonamide . Based on the method disclosed in the second synthesis, isothiocyanades carrying different substituents are treated with hydrazine monohydrate and thiosemicarbazide derivatives are obtained. The thiosemicarbazide derivatives obtained in the second synthesis and the sulphonamide derivatives obtained in the first synthesis (Compound 1 and Compound 2) are reacted to synthesize a total of 16 thiosemicarbazone derivatives carrying sulphonamide groups. The method of obtaining these synthesized compounds and their analysis results are given below .
Findings :
• Synthesis and analysis results of Compound 1 (4-acetyl- N-phenylbenzenesulphonamide ) : The values arranged by taking the multiples of the mole numbers disclosed in the above given first synthesis are provided below.
Compound 1 is synthesized according to the method disclosed in the first synthesis by using 3.4 grams (12.0 mmols) of 4- acetylbenzenesulphonylchloride and 1.23 grams (13.2 mmols) of aniline.
Obtaining efficiency of Compound 1 at the end of the synthesis is 44%. That is to say, about 1.5 grams of
Compound 1 is obtained.
Melting point of Compound 1 is about 83-84 °C. Compound 1 is an orange coloured substance in powder form.
Compound 1 is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate. However, it is insoluble in distilled water.
Molecular weight of Compound 1 is 275.32 g/mol.
Molecular formula of Compound 1 is C14H13NO3S, and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000007_0001
Table 1 : Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 1.
FT-IR analysis results for Compound 1 are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
Figure imgf000007_0002
Table 2 : FT-IR analysis results for Compound 1. H NMR results for Compound 1 are given in the following pages .
• (4-acetyl-N- ( 4-methoxyphenyl ) benzenesulphonamide )
synthesis and analysis results for Compound 2:
Compound 2 is synthesized according to the method disclosed in the first synthesis by using 3.5 grams (11 mmols) of 4- acetylbenzenesulphonylchloride and 1.21 grams (13 mmols) of 4-methoxyaniline .
The efficiency of Compound 2 at the end of the synthesis is 43%. That is to say, about 1.5 grams of Compound 2 is obtained .
Melting point of Compound 2 is about 114-115°C.
Compound 2 is a brown substance in powder form.
Compound 2 is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, However, it is insoluble in distilled water.
Molecular weight of Compound 2 is 305.84 g/mol.
Molecular formula of Compound 2 is C15H15NO4S, and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Theoretical Calculation Elemental Analysis Results Results (%) (%)
c 53.00 53.24
H 4.95 5.10 N 4.59 4.41
S 15.60 15.70
Table 3 : Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2. FT-IR analysis results for Compound 2 are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
Figure imgf000009_0001
Table : FT-IR analysis results for Compound 2.
H NMR results for Compound 2 are given in the following pages.
• (N-cyclohexyl-2- { 1- [ 4 -phenyl sulphamoyl
phenyl ] ethylidene } hydrazine carbothioamide ) synthesis and analysis results for Compound la:
0.58 mmol (0.16 gram) of 4-acetyl-N- phenylbenzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.58 mmol (0.1 gram) of N- cyclohexylhydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound la. This solid substance is crystallized by filtering and washing with ether. Obtaining efficiency of Compound la at the end of the synthesis is 92%.
Melting point of Compound la is about 228-230°C. Compound la is yellow.
Compound la is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , heated chloroform, and heated ethyl acetate. However, it is insoluble in distilled water.
Molecular weight of Compound la is 430.59 g/mol.
Molecular formula of Compound la is C21H26 4O2 S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000010_0001
Table 5 : Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound la.
FT-IR analysis results for Compound la are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band) (Bending band)
Figure imgf000011_0001
Table 6 : FT-IR analysis results for Compound la.
H NMR results for Compound la are given in the following pages .
• Synthesis and analysis results for Compound lb (N- phenyl-2- { 1- [ 4-phenylsulphamoylphenyl ]
ethylidene } hydrazine carbothioamide ) :
0.59 mmol (0.17 gram) of 4-acetyl-N- phenylbenzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.59 mmol (0.1 gram) of N- phenylhydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound lb. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound lb at the end of the synthesis is 92%.
Melting point of Compound lb is about 182-184°C.
Compound lb is yellow. Compound lb is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , and chloroform. However, it is insoluble in distilled water and ethyl acetate. Molecular weight of Compound lb is 424.54 g/mol.
Molecular formula of Compound lb is C21H20N4O2 S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000012_0001
Table 7 : Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound lb. FT-IR analysis results for Compound lb are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000012_0002
Table 8 : FT-IR analysis results for Compound lb.
H NMR results for Compound lb are given in the following pages .
• Synthesis and analysis results for Compound lc (N-(4- bromophenyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.41 mmol (0.11 gram) of 4-acetyl-N- phenylbenzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.41 mmol (0.1 kg) of N-(4- bromophenyl ) hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound lc. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound lc at the end of the synthesis is 72%.
Melting point of Compound lc is about 212-214°C. Compound lc is yellow.
Compound lc is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water.
Molecular weight of Compound lc is 503.44 g/mol. Molecular formula of Compound lc is C2iHigBrN402S2, and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000014_0001
Table 9 : Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound lc.
FT-IR analysis results for Compound lc are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000014_0002
H NMR results for Compound lc are given in the following pages. • Synthesis and analysis results for Compound Id (N-(4- chlorophenyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide ) :
0.50 mmol (0.14 gram) of 4-acetyl-N- phenylbenzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.50 mmol (0.1 gram) of N-(4- chlorophenyl ) hydrazine carbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound lc. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound Id at the end of the synthesis is 68%.
Melting point of Compound Id is about 213-215°C. Compound Id is yellow.
Compound Id is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water.
Molecular weight of Compound Id is 458.98 g/mol.
Molecular formula of Compound Id is C21H19C IN4O2 S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000015_0001
H 4.17 4.18
N 12.21 12.53
S 13.97 13.32
Table 11: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound Id. FT-IR analysis results for Compound Id are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000016_0001
H NMR results for Compound ld are given in the following pages .
• Synthesis and analysis results for Compound le (N-(4- methoxyphenyl ) -2- { 1- [ 4-
(phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide ) :
0.52 mmol (0.14 gram) of 4-acetyl-N- phenylbenzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.52 mmol (0.1 gram) of N-(4- methoxyphenyl ) hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound le. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound le at the end of the synthesis is 56%.
Melting point of Compound le is about 195-197°C. Compound le is light pink.
Compound le is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, However, it is insoluble in distilled water.
Molecular weight of Compound le is 454.57 g/mol.
Molecular formula of Compound le is C22H22N4O3S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000017_0001
Table 13: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound le. FT-IR analysis results for Compound le are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000018_0001
H NMR results for Compound le are given in the following pages .
• Synthesis and analysis results for Compound If (N-(4- methylthiophenyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide ) :
0.47 mmol (0.13 gram) of 4-acetyl-N- phenylbenzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.47 mmol (0.1 gram) of N-[4- (methylsulphanyl ) phenyl ] hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound If. This solid substance is crystallized by filtering and washing with ether. Obtaining efficiency of Compound If at the end of the synthesis is 67%.
Melting point of Compound If is about 176-178°C. Compound If is yellow.
Compound If is soluble in acetone, heated methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, However, it is insoluble in distilled water.
Molecular weight of Compound If is 470.54 g/mol.
Molecular formula of Compound If is C22H22 4O2 S 3 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000019_0001
Table 15: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound If.
FT-IR analysis results for Compound If are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band) N-H s.b. S=0 C=N, N-H (b.b. ) ; C=S, as . s . b . imine Aromatic Thioamide and S=0 s.b. ring C=C (s.b.) s . s . b . (s.b.)
3279 1346, 1583 1495, 1518 1200
1156
Table 16: FT-IR analysis results for Compound '. Lf .
H NMR results for Compound lf are given in the following pages .
• Synthesis and analysis results for Compound lg (N- (benzyl) -2-{l- [4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide ) :
0.55 mmol (0.15 gram) of 4-acetyl-N- phenylbenzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.55 mmol (0.1 gram) of N- benzylhydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound lg. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound lg at the end of the synthesis is 45%.
Melting point of Compound lg is about 183-185°C.
Compound lg is yellow. Compound lg is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water. Molecular weight of Compound lg is 438.57 g/mol.
Molecular formula of Compound lg is C22H22N4O2 S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000021_0001
Table 17: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound lg. FT-IR analysis results for Compound lg are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000021_0002
3250, 3141 1162
Table 18: FT-IR analysis results for Compound '. Lg.
H NMR results for Compound lg are given in the following pages .
• Synthesis and analysis results for Compound lh (N- (2- phenylethyl) -2-{l- [4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide ) :
0.51 mmol (0.14 gram) of 4-acetyl-N- phenylbenzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.51 mmol (0.1 gram) of N- (2- phenylethyl ) hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound lh. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound lh at the end of the synthesis is 84%.
Melting point of Compound lh is about 195-197°C. Compound lh is yellow.
Compound lh is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water.
Molecular weight of Compound lh is 452.57 g/mol. Molecular formula of Compound lh is C23H24N4O2 S2
theoretically calculated ingredient percentages
elemental analysis results are as follows.
Figure imgf000023_0001
Table 19: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound lh.
FT-IR analysis results for Compound lh are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000023_0002
H NMR results for Compound lh are given in the following pages.
• Synthesis and analysis results for Compound 2a (N- (cyclohexyl) -2-{l- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.58 mmol (0.17 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.58 mmol (0.1 gram) of N- cyclohexylhydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound 2a. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound 2a at the end of the synthesis is 47%.
Melting point of Compound 2a is about 220-221°C. Compound 2a is yellow.
Compound 2a is soluble in acetone, heated methanol, chloroform, and dimethyl sulphoxide (DMSO) . However, it is insoluble in ethyl acetate and distilled water.
Molecular weight of Compound 2a is 460.59 g/mol.
Molecular formula of Compound 2a is C22H28 4O3S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000024_0001
13.92 13.82
Table 21: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2a.
FT-IR analysis results for Compound 2a are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000025_0001
Table 22 : FT-IR analysis results for Compound results for Compound 2a are given in the following
• Synthesis and analysis results for Compound 2b (N- (phenyl) -2-{l- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.6 mmol (0.18 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.6 mmol (0.1 gram) of N- phenylhydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound 2b. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound 2b at the end of the synthesis is 24%.
Melting point of Compound 2b is about 190-191°C. Compound 2b is white.
Compound 2b is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
Molecular weight of Compound 2b is 454.81 g/mol.
Molecular formula of Compound 2b is C22H21N4O3S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000026_0001
Table 23: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2b.
FT-IR analysis results for Compound 2b are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000027_0001
Table 2 : FT-IR analysis results for Compound
H NMR results for Compound 2b are given in the following pages .
• Synthesis and analysis results for Compound 2c (N-(4- bromophenyl ) -2- { 1- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.41 mmol (0.12 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.41 mmol (0.1 gram) of N-(4- bromophenyl ) hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound 2c. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound 2c at the end of the synthesis is 54%.
Melting point of Compound 2c is about 230-232°C. Compound 2c is yellow.
Compound 2c is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
Molecular weight of Compound 2c is 534.67 g/mol.
Molecular formula of Compound 2c is C22H2iBrN403S2, and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000028_0001
Table 25: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2c.
FT-IR analysis results for Compound 2c are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000028_0002
s . s . b . ( s . b . )
3351, 1330, 1587 1487, 1508 1245 3257, 3186 1163
Table 26: FT-IR analysis results for Compound 2c
H NMR results for Compound 2c are given in the following pages .
• Synthesis and analysis results for Compound 2d (N-(4- chlorophenyl) -2-{l-[4-(4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.5 mmol (0.15 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.5 mmol (0.1 gram) of N-(4- chlorophenyl ) hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound 2d. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound 2d at the end of the synthesis is 43%.
Melting point of Compound 2d is about 227-228°C. Compound 2d is white.
Compound 2d is soluble in acetone, heated methanol, and dimethyl sulphoxide (DMSO) . However, it is insoluble in chloroform, ethyl acetate, and distilled water.
Molecular weight of Compound 2d is 488.98 g/mol. Molecular formula of Compound 2d is C22H21C IN4O3S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000030_0001
Table 27: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2d. FT-IR analysis results for Compound 2d are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000030_0002
Table 28: FT-IR analysis results for Compound 2d.
H NMR results for Compound 2d are given in the following pages . • Synthesis and analysis results for Compound 2e (N-(4- methoxyphenyl ) -2- { 1- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.52 mmol (0.16 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.52 mmol (0.1 gram) of N-(4- methoxyphenyl ) hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis .
Obtaining efficiency of Compound 2e at the end of the synthesis is 37%.
Melting point of Compound 2e is about 190-191°C. Compound 2e is light pink.
Compound 2e is soluble in acetone, chloroform, and dimethyl sulphoxide (DMSO) . However, it is insoluble in methanol, ethyl acetate, and distilled water.
Molecular weight of Compound 2e is 484.57 g/mol.
Molecular formula of Compound 2e is C23H24N4O4 S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000031_0001
13.23 13.57
Table 29: Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2e.
FT-IR analysis results for Compound 2e are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000032_0001
Table 30 : FT-IR analysis results for Compound results for Compound 2e are given in the following
• Synthesis and analysis results for Compound 2f (N-(4- methylthiophenyl) -2-{l-[4-(4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.47 mmol (0.14 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.47 mmol (0.1 gram) of N-[4- (methylsulphanyl ) phenyl ] hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound 2f. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound 2f at the end of the synthesis is 44%.
Melting point of Compound 2f is about 206-207°C. Compound 2f is brown.
Compound 2f is soluble in acetone, methanol, ethyl acetate, chloroform, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
Molecular weight of Compound 2f is 501.54 g/mol.
Molecular formula of Compound 2f is C24H26 4O3S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000033_0001
Table 31 : Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2f.
FT-IR analysis results for Compound 2f are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000034_0001
Table 32 : FT-IR analysis results for Compound
H NMR results for Compound 2f are given in the following pages .
• Synthesis and analysis results for Compound 2g (N- (benzyl) -2-{l- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.55 mmol (0.17 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.55 mmol (0.1 gram) of N- benzylhydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound 2g at the end of the synthesis is 52%.
Melting point of Compound 2g is about 238-239°C. Compound 2g is light yellow.
Compound 2g is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
Molecular weight of Compound 2g is 467.57 g/mol.
Molecular formula of Compound 2g is C23H24N4O3S2 , and the theoretically calculated ingredient percentages and the elemental analysis results are as follows.
Figure imgf000035_0001
Table 33 : Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2g.
FT-IR analysis results for Compound 2g are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000035_0002
s . s . b . ( s . b . )
3344, 3221 1331, 1593 1491, 1524 1216
1152
Table 3 : FT-IR analysis results for Compound
H NMR results for Compound 2g are given in the following pages .
• Synthesis and analysis results for Compound 2h (N- (2- phenylethyl) -2-{l- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) :
0.52 mmol (0.16 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide is dissolved in 15 mL of methanol and then added onto 0.52 mmol (0.1 gram) of N- (2- phenylethyl ) hydrazinecarbothioamide dissolved in 5 mL of heated methanol as in the method disclosed in the third synthesis. The solid substance obtained in the reaction is Compound 2h. This solid substance is crystallized by filtering and washing with ether.
Obtaining efficiency of Compound 2h at the end of the synthesis is 42%.
Melting point of Compound 2h is about 191-192°C. Compound 2h is white.
Compound 2h is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) . However, it is insoluble in distilled water.
Molecular weight of Compound 2h is 482.61 g/mol. Molecular formula of Compound 2h is C24H26N4O3S2
theoretically calculated ingredient percentages
elemental analysis results are as follows.
Figure imgf000037_0001
Table 35 : Theoretically calculated ingredient percentages and ingredient percentages determined as a result of elemental analysis of Compound 2h. FT-IR analysis results for Compound 2h are given below in terms of wave number (cnf1) . The meanings of the abbreviations used in the below given table are as follows: s.b. (Stretching band)
s.s.b. (Symmetric stretching band)
as. s.b. (Asymmetric stretching band)
b.b. (Bending band)
Figure imgf000037_0002
Table 36: FT-IR analysis results for Compound 2h.
H NMR results for Compound 2h are given in the following pages . The mechanism of the reaction between the 4-acetylbenzene sulphonylchloride compound that is selected as the starting material of the first synthesis and the aniline derivatives are shown in Figures 21 and 22. Compound 1 or Compound 2 is synthesized according to the hydrogen or methoxy group found in the para position of the aniline derivative used here. In the mechanisms of Figure 21 and 22, one of the n electrons of the S=0 double bond shifts onto one of the oxygen atoms as a result of the attack of the non-pooled electrons of the nitrogen (N) atom found in aniline to the sulphur (S) atom having electrophilic characteristic. As a result of the shift of n electrons to form n bond, chlorine (CI) atom is separated from the structure and one of the hydrogen (H) atoms found on the nitrogen (N) is separated and thus the product is formed.
In the second synthesis, p-substitutedphenyl thiosemicarbazide derivatives are obtained as a result of the interaction of p-substitutedphenyl isothiocyanade derivatives with hydrazine monohydrate in diethylether . When the reaction mechanism shown in Figure 23 is analyzed, it can be seen that, when the hydrazine (:NH2NH2) nucleophile attacks the carbon (C) atom found in the isothiocyanade, n electrons are opened on the nitrogen (N) atom, which is more electronegative than the sulphur (S) atom. Thiosemicarbazide derivatives are obtained with the re-arrangement of the molecule due to a shift of a proton found within the molecule .
In the third synthesis, 4-acetyl-N-
( substituted) benzenesulphonamide derivatives are reacted with p-substitutedphenyl thiosemicarbazide to obtain p- substitutedphenyl thiosemicarbazone derivatives. When the reaction mechanism shown in Figure 24 is analyzed, it can be seen that, the nitrogen (N) atom found at the amino end of the thiosemicarbazide attacks the carbonyl carbon (C) of the nitrogen (N) atom. This is because the nitrogen (N) atom found at the amino end has more nucleophilic characteristic than the nitrogen (N) atom of the thioamide group. Following nucleophilic attack, carbonylamine is formed as an unstable intermediate product in the reaction medium. P- substitutedphenyl thiosemicarbazone derivatives are obtained with the re-arrangement of this structure due to the proton transfer within the structure and release of water. HC1 is used in order to provide an acidic medium during the synthesis of p-substitutedphenyl thiosemicarbazone derivatives and the reaction efficiencies are observed to vary between 24-96%.
1H NMR spectra of the synthesized compounds are shown below. These spectra are taken in a spectrometer device at 400 MHz frequency and the solution is prepared by dissolving about 10 mg of compound in DMSO-d6 for analysis purposes and the prepared solution is analyzed. The chemical shift values of the peaks are evaluated as ppm (parts per million) concentration and the interaction coefficients are given as Hz .
Figure imgf000040_0001
Figure imgf000041_0001
Table 37 : H MR results for synthesized compounds [la-c] .
Figure imgf000042_0001
Table 38 : H NMR results for synthesized compounds [ld-h] .
Figure imgf000043_0001
Table 40: H NMR results for synthesized compounds [2d-h] .
C NMR spectra of the synthesized compounds are taken from a solution of 20 milligrams (mg) of substance in CDCI3 and DMSO-d6, in a spectrometer device at 400 MHz frequency. In said spectra, tetramethylsilane (TMS) is accepted as standard. The chemical shift values of the determined peaks are evaluated as ppm (parts per million) concentration and the interaction coefficients are given as Hz. 13C NMR results for Compound lc, lh, 2a, and 2h in the thiosemicarbazone derivatives synthesized according to the method of the invention are given below.
Figure imgf000044_0001
Table 41: C NMR results for synthesized compounds [lc, lh, 2a,
2h]
Thin-layer chromatography (TLC) is used for monitoring the process of reactions during the synthesis works and determining the purity levels of obtained compounds. For this purpose, 20x20 cm chromatographic plates coated with 0-25 millimetre (mm) thickness of silica gel are used as adsorbent. Ethyl acetate and n-hexane (3:2, 3:1, 1:1) are used as solvent system. The operation of sweeping the solvent on the plates is performed after solvent systems are placed in chromatography tanks at room temperature and the tanks are saturated with solvent vapour. After the sweeping operation is complete, in order to make the stains found on the air-dried plates visible, the plates are required to be observed under UV light at 254 nanometres (nm) wavelength. In order to obtain a clearer view, the plates should be placed in a closed tank saturated with iodine vapour. In the third synthesis, which is the synthesis of thiosemicarbazide derivatives, while the reaction is being monitored, dimethylamino benzaldehyde (DAB) reagent is sprayed into the reaction medium and the presence of hydrazine hydrate residue is determined in the medium.
FT-IR (Fourier Transform-Infrared) spectra is obtained in the wave number of 4000-400 cnf1 and via direct solid sample. FT-IR analysis results of synthesized compounds are shown in the below given Tables 42 and 43.
Theoretically calculated ingredient percentages and elemental analysis (CHNS) results of synthesized compounds are given below in Tables 44 and 45.
Below given Tables 46 and 47 show the closed formulas, molecular weights, melting points, and obtaining efficiencies of synthesized compounds.
Figure imgf000046_0001
Table 42: FT-IR results of synthesized compounds [la-h]
Figure imgf000047_0001
Table 43: FT-IR results of synthesized compounds [2a-h] .
Figure imgf000048_0001
Table 44: Closed formulas, theoretically calculated ingredient percentages, and elemental analysis (CHNS determination) results of synthesized compounds [ 1 , la-h] .
Figure imgf000049_0001
Table 45: Closed formulas, theoretically calculated ingredient percentages, and elemental analysis (CHNS determination) results of synthesized compounds [2, 2a-h] .
Figure imgf000050_0001
Table 46: Closed formulas, molecular weights, melting points, and obtaining efficiencies synthesized compounds [1, 2, la-g] .
Figure imgf000051_0001
Table 47: Closed formulas, molecular weights, melting points, and obtaining efficiencies synthesized compounds [lh, 2a-h] .
Description of the Figures
Figure 1: Chemical structure of Compound 1 (4-acetyl-N- phenylbenzenesulphonamide ) that is the product of the first synthesis .
Figure 2: Chemical structure of Compound 2 (4-acetyl-N-
(methoxyphenyl ) benzenesulphonamide ) that is the product of the second synthesis.
Figure 3: Chemical structure of Compound la (N-cyclohexyl-2-
{ 1- [ 4 -phenyl sulphamoylphenyl ] ethylidene } hydrazine
carbothioamide ) that is the product of the third synthesis.
Figure 4: Chemical structure of Compound lb (N-phenyl-2- { 1-
[ 4 -phenyl sulphamoylphenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis.
Figure 5: Chemical structure of Compound lc (N-(4- bromophenyl ) -2- { 1- [ 4-
(phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis.
Figure 6: Chemical structure of Compound Id (N-(4- chlorophenyl ) -2- { 1- [ 4- (phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis.
Figure 7: Chemical structure of Compound le (N-(4- methoxyphenyl ) -2- { 1-
(phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis.
Figure 8: Chemical structure of Compound If (N-(4- methylthiophenyl ) -2- { 1- [ 4-
(phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis. Figure 9: Chemical structure of Compound lg (N- (benzyl ) -2-
{1- [4- (phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis. Figure 10: Chemical structure of Compound lh (N- (2- phenylethyl) -2-{l- [4- (phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide ) that is the product of the third synthesis. Figure 11: Chemical structure of Compound 2a (N- (cyclohexyl) -2-{l- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis. Figure 12: Chemical structure of Compound 2b (N- (phenyl ) -2- {1- [4- (4-methoxyphenylsulphamoyl ] phenyl ] ethylidene } hydrazine carbothioamide) that is the product of the third synthesis. Figure 13: Chemical structure of Compound 2c (N-(4- bromophenyl ) -2- { 1- [4- (4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis.
Figure 14: Chemical structure of Compound 2d (N-(4- chlorophenyl) -2- { 1- [4- (4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis.
Figure 15: Chemical structure of Compound 2e (N-(4- methoxyphenyl ) -2- { 1- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis.
Figure 16: Chemical structure of Compound 2f (N-(4- methylthiophenyl) -2-{l-[4-(4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis.
Figure 17: Chemical structure of Compound 2g (N- (benzyl ) -2- {1- [4- (4-methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide) that is the product of the third synthesis. Figure 18: Chemical structure of Compound 2h (N- (2- phenylethyl) -2- { 1- [4- (4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) that is the product of the third synthesis. Figure 19: Chemical structure showing the protons of Compound la (N-cyclohexyl-2- { 1- [ 4- phenylsulphamoylphenyl ] ethylidene } hydrazine carbothioamide ) , Compound lb (N-phenyl-2- { 1- [ 4- phenylsulphamoylphenyl ] ethylidene } hydrazine carbothioamide) , Compound lc (N- ( 4-bromophenyl ) -2- { 1- [ 4- (phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), Compound Id (N- ( chlorophenyl ) -2- { 1- [ 4- (phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), Compound le (N- ( 4-methoxyphenyl ) -2- { 1- [ 4- (phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), Compound If (N- ( 4-methylthiophenyl ) -2- { 1-
[4- (phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), Compound lg (N- (benzyl ) -2- { 1- [ 4-
(phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), and Compound lh (N- (2-phenylethyl ) -2- { 1- [ 4- (phenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide) when Compound 1 (4-acetyl-N- phenylbenzenesulphonamide ) is used as the starting material in the third synthesis.
Figure 20: Chemical structure showing the protons of Compound 2a (N- (cyclohexyl) -2- { 1- [4- (4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), Compound 2b (N- (phenyl ) -2- { 1- [ 4- ( 4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), Compound 2c (N- ( 4-bromophenyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), Compound 2d (N- ( 4-chlorophenyl ) -2- { 1- [ 4- ( 4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), Compound 2e (N- ( 4-methoxyphenyl ) -2- { 1- [ 4- ( 4-methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ), Compound 2f (N- ( 4-methylthiophenyl ) -2- { 1- [ 4-
( 4-methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide), Compound 2g (N- (benzyl ) -2- { 1- [ 4- ( 4- methoxyphenyl sulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide), and Compound 2h (N- (2-phenylethyl) -2- { 1- [4- ( 4-methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide ) when Compound 2 ( 4-acetyl-N- ( 4- methoxyphenyl ) benzenesulphonamide ) is used as the starting material in the third synthesis.
Figure 21: The mechanism for obtaining Compound 1 (4-acetyl- N-phenylbenzenesulphonamide ) that is the sulphonamide derivative product of the first synthesis.
Figure 22: The mechanism for obtaining Compound 2 (4-acetyl- N- ( 4-methoxyphenyl ) benzenesulphonamide ) that is the sulphonamide derivative product of the first synthesis.
Figure 23: The mechanism for obtaining the second synthesis product thiosemicarbazide derivatives.
Figure 24: The mechanism for obtaining the third synthesis product thiosemicarbazone derivatives.

Claims

1. A synthesis method of thiosemicarbazone derivatives, characterized in that; it comprises the process steps of:
- in the first synthesis; reacting 4-acetylbenzene sulphonylchloride with aniline or p-methoxyaniline, at room temperature, in the presence of dichloromethane,
- as a result of this reaction; formation of Compound 1 (4- acetyl-N-phenylbenzenesulphonamide ) , which is a sulphonamide derivative, or Compound 2 ( 4-acetyl-N- ( 4-methoxyphenyl ) benzene sulphonamide) ;
in the second synthesis; reacting 4-substitutedphenyl isothiocyanade derivatives with hydrazine monohydrate, in the presence of diethylether, at room temperature;
- as a result of this reaction; formation of thiosemicarbazide derivatives ;
- in the third synthesis; reacting a sulphonamide derivative obtained in the first synthesis with a thiosemicarbazide derivative obtained in the second synthesis, in the presence of methyl alcohol, by heating;
- as a result of this reaction; formation of thiosemicarbazone derivatives .
2 . The synthesis method of thiosemicarbazone derivatives according to Claim 1, characterized in that; in the first synthesis, it comprises the process steps of:
- dissolving 1.17 mmol of aniline or p-methoxyaniline in 10 ml of dichloromethane;
adding 1.06 mmol triethylamine and 1-3 drops of pyridine onto this mixture as catalysts;
- mixing this mixture at room temperature for 15 minutes;
- in a separated part, dissolving 1.06 mmol of 4- acetylbenzenesulphonyl chloride in 5 mL of dichloromethane and adding onto the above prepared mixture; - heating the mixture during and/or following this addition;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- applying extraction operation on the cooled mixture via 2 M hydrochloric acid (HC1);
drying organic phases with sodium sulphate following extraction operation;
washing the crystals formed as a result of the drying operation with petroleum ether; and
- obtaining 4-acetyl-N-phenylbenzenesulphonamide or 4-acetyl- N- ( 4-methoxyphenyl ) benzenesulphonamide following washing operation .
3 . The synthesis method of thiosemicarbazone derivatives according to Claim 1, characterized in that; in the second synthesis, it comprises the process steps of:
dissolving 1 mmol 4-substitutedphenyl isothiocyanade derivative in diethylether;
- adding 1 mmol hydrazine monohydrate dissolved in diethylether into this mixture;
- formation of solid substances at the bottom of the mixture following the addition;
- taking these solid substances from the mixture vessel;
- crystallization of these solid substances in a solvent; and obtaining thiosemicarbazide derivatives following crystallization operation.
4 . The synthesis method of thiosemicarbazone derivatives according to Claim 1, characterized in that; in the third synthesis, it comprises the process steps of:
- dissolving thiosemicarbazide derivative in heated methanol; - adding sulphonamide derivative, which has the same number of moles with the thiosemicarbazide derivative that was added first, dissolved in methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances in a solvent; and obtaining thiosemicarbazone derivatives following crystallization operation.
5 . The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.58 mmol (0.1 gram) of N- cyclohexylhydrazinecarbothioamide in 5 mL of heated methanol; - adding 0.58 mmol (0.16 gram) of 4-acetyl-N- phenylbenzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N-cyclohexyl-2- { 1- [ 4-phenylsulphamoylphenyl ] ethylidene } hydrazine following crystallization operation.
6. The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.59 mmol (0.1 gram) of N- phenylhydrazinecarbothioamide in 5 mL of heated methanol;
adding 0.59 mmol (0.17 gram) of 4-acetyl-N- phenylbenzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N-phenyl-2- { 1- [ 4- (phenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioamide following crystallization operation.
7 . The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
- dissolving 0.41 mmol (0.1 gram) of N-(4- bromophenyl ) hydrazinecarbothioamide in 5 mL of heated methanol ;
adding 0.41 mmol (0.11 gram) of 4-acetyl-N- phenylbenzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature; - formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- ( 4-bromophenyl ) -2- { 1- [ 4- (phenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide following crystallization process.
8 . The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.50 mmol (0.1 gram) of N-(4- chlorophenyl ) hydrazine carbothioamide in 5 mL of heated methanol;
adding 0.50 mmol (0.14 gram) of 4-acetyl-N- phenylbenzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- ( 4-chlorophenyl ) -2- { 1- [ 4- (phenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide following crystallization process.
9. The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of: dissolving 0.52 mmol (0.1 gram) of N-(4- methoxyphenyl ) hydrazine carbothioamide in 5 mL of heated methanol ;
adding 0.52 mmol (0.14 grams) of 4-acetyl-N- phenylbenzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- ( 4-methoxyphenyl ) hydrazinecarbothioamide following crystallization operation.
10 . The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.47 mmol (0.1 gram) of N-[4-
(methylsulphanyl ) phenyl ] hydrazinecarbothioamide in 5 mL of heated methanol;
- adding 0.47 mmol (0.13 gram) of 4-acetyl-N- phenylbenzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture; - crystallization of these solid substances by washing with ether;
obtaining N- ( 4-methylthiophenyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide following crystallization process.
11. The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
- dissolving 0.55 mmol (0.1 gram) of N- benzylhydrazinecarbothioamide in 5 mL of heated methanol;
adding 0.55 mmol (0.15 gram) of 4-acetyl-N- phenylbenzenesulphonamide dissolved in 15 mL of methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- (benzyl ) -2- { 1- [ 4- (phenylsulphamoyl ) phenyl ] ethylidene} hydrazine carbothioamide following crystallization process .
12. The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.51 mmol (0.1 gram) of N- (2- phenylethyl ) hydrazine carbothioamide in 5 mL of heated methanol ; adding 0.51 mmol (0.14 gram) of 4-acetyl-N- phenylbenzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- ( 2-phenylethyl ) -2- { 1- [ 4- (phenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide following crystallization process.
13. The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
- dissolving 0.58 mmol (0.1 gram) of N- cyclohexylhydrazinecarbothioamide in 5 mL of heated methanol; adding 0.58 mmol (0.17 gram) of 4-acetyl-N- ( 4- methoxyphenyl ) benzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether; obtaining N- (cyclohexyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide following crystallization process.
14 . The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.6 mmol (0.1 gram) of N- phenylhydrazinecarbothioamide in 5 mL of heated methanol;
- adding 0.6 mmol (0.18 gram) of 4-acetyl-N- ( 4- methoxyphenyl ) benzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- (phenyl) -2- { 1- [4- (4-methoxyphenylsulphamoyl) phenyl ] ethylidene } hydrazine carbothioamide following crystallization process.
15 . The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.41 mmol (0.1 gram) of N-(4- bromophenyl ) hydrazinecarbothioamide in 5 mL of heated methanol ;
adding 0.41 mmol (0.12 gram) of 4-acetyl-N- ( 4- methoxyphenyl ) benzenesulphonamide dissolved in 15 mL methanol onto this mixture; - heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
- obtaining N- ( 4-bromophenyl ) -2- { 1- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide following crystallization process.
16 . The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.5 mmol (0.1 gram) of N-(4- chlorophenyl ) hydrazinecarbothioamide in 5 mL of heated methanol ;
- adding 0.5 mmol (0.15 gram) of 4-acetyl-N- ( 4- methoxyphenyl ) benzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- ( 4-chlorophenyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide following crystallization process.
17. The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
- dissolving 0.52 mmol (0.1 gram) of N-(4- methoxyphenyl ) hydrazinecarbothioamide in 5 mL of heated methanol ;
adding 0.52 mmol (0.16 gram) of 4-acetyl-N- ( 4- methoxyphenyl ) benzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
- obtaining N- ( 4-methoxyphenyl ) -2- { 1- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide following crystallization process.
18. The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.47 mmol (0.1 gram) of N-[4-
(methylsulphanyl ) phenyl ] hydrazinecarbothioamide in 5 mL of heated methanol;
- adding 0.47 mmol (0.14 gram) of 4-acetyl-N- ( 4- methoxyphenyl ) benzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours; - completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- ( 4-methylthiophenyl ) -2- { 1- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide following crystallization process.
19 . The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.55 mmol (0.1 gram) of N- benzylhydrazinecarbothioamide in 5 mL of heated methanol;
adding 0.55 mmol (0.17 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
- obtaining N- (benzyl) -2- { 1- [4- ( 4-methoxyphenylsulphamoyl ) phenyl] ethylidene } hydrazinecarbothioamide following crystallization operation.
20. The synthesis method of thiosemicarbazone derivatives according to Claim 4, characterized in that; it comprises the process steps of:
dissolving 0.52 mmol (0.1 gram) of N- (2- phenylethyl ) hydrazinecarbothioamide in 5 mL of heated methanol ;
adding 0.52 mmol (0.16 gram) of 4-acetyl-N- (4- methoxyphenyl ) benzenesulphonamide dissolved in 15 mL methanol onto this mixture;
- heating this reaction mixture for 48 hours;
- completion of the reaction when the starting material of the mixture is used up, and then cooling of the mixture to the room temperature;
- formation of solid substances at the bottom of the mixture following the cooling operation;
- removing the formed solid substances from the mixture;
- crystallization of these solid substances by washing with ether;
obtaining N- ( 2-phenylethyl ) -2- { 1- [4- (4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazine
carbothioamide following crystallization process.
21. Sulphonamide derivatives obtained with a method according to Claim 2.
22. Sulphonamide derivatives according to Claim 21, characterized in comprising:
- the compound of 4-acetyl-N-phenylbenzenesulphonamide, which has a molecular formula of C14H13NO3S and molecular weight of 275.32 g/mol which
- has a melting point of 83-84°C,
- has dust form and orange colour,
- is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, and - is insoluble in distilled water.
23 . Sulphonamide derivatives according to Claim 21, characterized in comprising:
the compound of 4-acetyl-N- ( 4- methoxyphenyl ) benzenesulphonamide, which has a molecular formula of C15H15NO4S and molecular weight of 305.84 g/mol which
- has a melting point of 114-115°C,
- has dust form and brown colour,
- is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, and
- is insoluble in distilled water.
24 . Thiosemicarbazide derivatives obtained with a method according to Claim 3.
25 . Thiosemicarbazone derivatives obtained with a method according to any one of Claims 4 to 20.
26 . Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N-cyclohexyl-2- { 1- [ 4- phenylsulphamoylphenyl ] ethylidene } hydrazine, which has a molecular formula of C21H26 4O2 S2 and molecular weight of 430.59 g/mol which
- has a melting point of 228-230°C,
- has yellow colour,
- is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , heated chloroform, and heated methyl acetate, and
- is insoluble in distilled water.
27. Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N-phenyl-2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazine carbothioamide, which has a molecular formula of C21H20 4O2 S2 and molecular weight of 424.54 g/mol which
- has a melting point of 182-184°C,
- has yellow colour,
- is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , and chloroform, and
- is insoluble in distilled water and ethyl acetate.
28. Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
- the compound of N- ( 4-bromophenyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazinekarbothioamide, which has a molecular formula of C2iHi9BrN402S2 and molecular weight of 503.44 g/mol which
- has a melting point of 212-214°C,
- has yellow colour,
is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) ,
is insoluble in chloroform, ethyl acetate, and distilled water .
29. Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- ( 4-chlorophenyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioamide, which has a molecular formula of C21H19C IN4O2 S2 and molecular weight of 458.98 g/mol which
- has a melting point of 213-215°C,
- has yellow colour, is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) ,
is insoluble in chloroform, ethyl acetate, and distilled water .
30. Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- ( 4-methoxyphenyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioamide, which has a molecular formula of C22H22 4O3S2 and molecular weight of 454.57 g/mol which
- has a melting point of 195-197°C,
- has light pink colour,
- is soluble in acetone, methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, and
- is insoluble in distilled water.
31. Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
- the compound of N- ( 4-methylthiophenyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioamide, which has a molecular formula of C22H22 4O2 S 3 and molecular weight of 470.54 g/mol which
- has a melting point of 176-178°C,
- has yellow colour,
- is soluble in acetone, heated methanol, dimethyl sulphoxide (DMSO) , chloroform, and ethyl acetate, and
- is insoluble in distilled water.
32. Thiosemicarbazone derivatives according to Claim 25 characterized in comprising:
the compound of N- (benzyl ) -2- { 1- [ 4
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioamide, which has a molecular formula of C22H22N4O2 S2 and molecular weight of 438.57 g/mol which
- has a melting point of 183-185°C,
- has yellow colour,
- is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) ,
is insoluble in chloroform, ethyl acetate, and distilled water .
33 . Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- ( 2-phenylethyl ) -2- { 1- [ 4-
(phenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioamide, which has a molecular formula of C23H24N4O2 S2 and molecular weight of 452.57 g/mol which
- has a melting point of 195-197°C,
- has yellow colour,
is soluble in acetone, methanol, and dimethyl sulphoxide (DMSO) ,
- is insoluble in chloroform, ethyl acetate, and distilled water .
34 . Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
- the compound of N- (cyclohexyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioam ide, which has a molecular formula of C22H28 4O3S2 and molecular weight of 460.59 g/mol which
- has a melting point of 220-221°C,
- has yellow colour,
is soluble in acetone, heated methanol, chloroform, and dimethyl sulphoxide (DMSO) ,
- is insoluble in ethyl acetate and distilled water.
35 . Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- (phenyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioam ide, which has a molecular formula of C22H21 4O3S2 and molecular weight of 454.81 g/mol which
- has a melting point of 190-191°C,
- has white colour,
- is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) ,
- is insoluble in distilled water.
36 . Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
- the compound of N- ( 4-bromophenyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioam ide, which has a molecular formula of C22H2iBrN403S2 and molecular weight of 534.67 g/mol which
- has a melting point of 230-232°C,
- has yellow colour,
- is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) ,
- is insoluble in distilled water.
37 . Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- ( 4-chlorophenyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioam ide, which has a molecular formula of C22H21C IN4O3S2 and molecular weight of 488.98 g/mol which
- has a melting point of 227-228°C,
- has white colour,
is soluble in acetone, heated methanol, and dimethyl sulphoxide (DMSO) , is insoluble in chloroform, ethyl acetate, and distilled water .
38 . Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- ( 4-methoxyphenyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioam ide, which has a molecular formula of C23H24N4O4 S2 and molecular weight of 484.57 g/mol which
- has a melting point of 190-191°C,
- has light pink colour,
- is soluble in acetone, chloroform, and dimethyl sulphoxide (DMSO) ,
is insoluble in methanol, ethyl acetate, and distilled water.
39 . Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- ( 4-methylthiophenyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioam ide, which has a molecular formula of C24H26 4O3S2 and molecular weight of 501.54 g/mol which
- has a melting point of 206-207°C,
- is brown,
- is soluble in acetone, methanol, ethyl acetate, chloroform, and dimethyl sulphoxide (DMSO) ,
- is insoluble in distilled water.
40. Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- (benzyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioam ide, which has a molecular formula of C23H24N4O3S2 and molecular weight of 467.57 g/mol which - has a melting point of 238-239°C,
- has yellow colour,
- is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) ,
- is insoluble in distilled water.
41. Thiosemicarbazone derivatives according to Claim 25, characterized in comprising:
the compound of N- ( 2-phenylethyl ) -2- { 1- [ 4- ( 4- methoxyphenylsulphamoyl ) phenyl ] ethylidene } hydrazinecarbothioam ide, which has a molecular formula of C24H26 4O3S2 and molecular weight of 482.61 g/mol which
- has a melting point of 191-192°C,
- has white colour,
- is soluble in acetone, methanol, chloroform, ethyl acetate, and dimethyl sulphoxide (DMSO) ,
- is insoluble in distilled water.
PCT/TR2015/050283 2015-01-07 2015-12-29 Synthesis of thiosemicarbazone derivatives comprising sulphonamide group with potential anticonvulsant activity WO2016111658A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TRTR2015/00159 2015-01-07
TR2015000159 2015-01-07

Publications (1)

Publication Number Publication Date
WO2016111658A1 true WO2016111658A1 (en) 2016-07-14

Family

ID=56356234

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2015/050283 WO2016111658A1 (en) 2015-01-07 2015-12-29 Synthesis of thiosemicarbazone derivatives comprising sulphonamide group with potential anticonvulsant activity

Country Status (1)

Country Link
WO (1) WO2016111658A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090186900A1 (en) * 2006-02-27 2009-07-23 Nigel Vicker Compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090186900A1 (en) * 2006-02-27 2009-07-23 Nigel Vicker Compound

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
D.M. WILES, ET AL.: "Synthesis and properties of some formylferrocene thiosemicarbazones", CANADIAN JOURNAL OF CHEMISTRY, vol. 46, no. 11, June 1968 (1968-06-01), National Research Council, Ottawa, CA, pages 1865 - 1871, XP055261551, ISSN: 0008-4042, DOI: 10.1139/v68-310 *
DATABASE REGISTRY [online] Chemical Abstracts Service, Columbus, OH, US; 27 September 2004 (2004-09-27), XP002755936, Database accession no. 752214-67-8 *
E. ROSATELLI, ET AL.: "Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 24, no. 15, 3 June 2014 (2014-06-03), Elsevier Science Publishers, Oxford, GB, pages 3422 - 3425, XP028864133, ISSN: 0960-894X, DOI: 10.1016/j.bmcl.2014.05.086 *
J.R. DIMMOCK, ET AL.: "(Aryloxy)aryl semicarbazones and related compounds: A novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen", JOURNAL OF MEDICINAL CHEMISTRY, vol. 39, no. 20, 27 September 1996 (1996-09-27), American Chemical Society, Washington, DC, US, pages 3984 - 3997, XP009133975, ISSN: 0022-2623, DOI: 10.1021/jm9603025 *
J.V. RAGAVENDRAN, ET AL.: "Newer GABA derivatives for the treatment of epilepsy including febrile seizures: A bioisosteric approach", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, no. 12, 6 February 2008 (2008-02-06), Editions Scientifiques Elsevier, Paris, FR, pages 2650 - 2655, XP025714711, ISSN: 0223-5234, [retrieved on 20080206], DOI: 10.1016/j.ejmech.2008.01.036 *
M.A. AFFAN, ET AL.: "Triorganotin(IV) complexes of pyruvic acid-(4)-cyclohexylthiosemicarbazone (HPACT): Synthesis, characterisation, crystal structure andantibacterial activity", POLYHEDRON, vol. 33, no. 1, 25 November 2011 (2011-11-25), Elsevier Science Publishers, Amsterdam, NL, pages 19 - 24, XP028443689, ISSN: 0277-5387, DOI: 10.1016/j.poly.2011.11.021 *
Ö. GÜZEL, ET AL.: "Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 16, no. 19, 27 August 2008 (2008-08-27), Elsevier Science Publishers, Oxford, GB, pages 8976 - 8987, XP025468957, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2008.08.050 *
P. YOGEESWARI, ET AL.: "Anticonvulsant and neurotoxicity evaluation of some 6-chlorobenzothiazolyl-2-thiosemicarbazones", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 3, March 2002 (2002-03-01), Editions Scientifiques Elsevier, Paris, FR, pages 231 - 236, XP004372937, ISSN: 0223-5234, DOI: 10.1016/s0223-5234(02)01338-7 *
R.N. PRABHU, ET AL.: "Ruthenium(II) mediated C-H activation of substituted acetophenone thiosemicarbazones: Synthesis, structural characterisation, luminescence and electrochemical properties", JOURNAL OF ORGANOMETALLIC CHEMISTRY, vol. 694, no. 26, 10 September 2009 (2009-09-10), Elsevier-Sequoia, Lausanne, CH, pages 4170 - 4177, XP026722351, ISSN: 0022-328X, [retrieved on 20090910], DOI: 10.1016/j.jorganchem.2009.09.010 *
S. SERRA, ET AL.: "Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 82, 15 May 2014 (2014-05-15), Editions Scientifiques Elsevier, Paris, FR, pages 96 - 105, XP028872846, ISSN: 0223-5234, DOI: 10.1016/j.ejmech.2014.05.044 *

Similar Documents

Publication Publication Date Title
JP5699152B2 (en) Lysine-specific demethylase-1 inhibitors and uses thereof
KR101719550B1 (en) Diglycidic ether derivative therapeutics and methods for their use
KR101206843B1 (en) Tubulin inhibitors
JP5015919B2 (en) 18F or 11C labeled alkylthiophenylguanidine for imaging
EP1786773A1 (en) Isoindolin-1-one derivatives
KR20150053257A (en) Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives
JPS6110528A (en) Phenol derivative, manufacture and antiestrogenic medicinal composition
PL194745B1 (en) Substituted compounds of 2-benzylamino-2-phenyl acetamide, pharmaceutical composition containing same and application thereof
EP0662971B1 (en) 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM
EP2017257A1 (en) 2-aminobutanol compound and use thereof for medical purposes
JP2018527363A (en) Linagliptin crystal form and method for producing the same
EP2094674B1 (en) A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
CA2701638A1 (en) Pharmaceutical calcimimetics
WO2016111658A1 (en) Synthesis of thiosemicarbazone derivatives comprising sulphonamide group with potential anticonvulsant activity
Godfroid et al. Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity
RU2006114673A (en) NEW DERIVATIVES 4A, 5,9,10,11,12-HEXAHYDROBENZENOFURO- [3A, 3.2] [2] BENZAZEPINE, METHOD FOR PRODUCING THEM, AND ALSO APPLICATION FOR PRODUCING MEDICINES
EP2842937A1 (en) Amine compound and use thereof for medical purposes
EP3409671B1 (en) Isothiazole derivatives as gpr120 agonists for the treatment of type ii diabetes
US6825193B2 (en) Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
FI91251C (en) The method prepares pharmacologically valuable phenoxyethylamine derivatives
Doubsky et al. Synthesis of Fingolimod Employing Regioselective Aziridine Ring-Opening Reaction as a Key Step
CA3016253A1 (en) Sulfamate derivative compounds, processes for preparing them and their uses
EP0119107A1 (en) Derivatives of bicyclo(4.2.0)octatriene-1,3,5, their preparation and their therapeutical application
TR201500159A2 (en) Synthesis of thiosemicarbazone derivatives containing sulfonamide group with potential anticonvulsant activity.
WO2017210371A2 (en) Compounds as inhibitors of sodium channels

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15834773

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15834773

Country of ref document: EP

Kind code of ref document: A1